News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Brian Carlin

Advertisement

Brian Carlin is president and owner of Carlin Pharma Consulting LLC.

Articles by Brian Carlin

Beige cosmetic or make up powder isolated on white. | Image Credit:©triocean – stock.adobe.com

Understanding Excipient Characteristics to Ensure Robust Continuous Manufacturing

ByKrizia M. Karry,Brian Carlin,Nigel Langley,R. Christian Moreton,David Schoneker,Katherine L. Ulman,Joseph Zeleznik
June 13th 2024

Key information is needed for excipients and their potential impact on continuous manufacturing processes.

Advertisement

Latest Updated Articles

  • Beige cosmetic or make up powder isolated on white. | Image Credit:©triocean – stock.adobe.com
    Understanding Excipient Characteristics to Ensure Robust Continuous Manufacturing

    Published: June 13th 2024 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Everything to Know About Pharmaceutical Tariffs in 2025

2

Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars

3

New Dosage Forms and Delivery Systems Driving 505(b)(2) Success

4

Challenges for the Global Manufacturing of Vaccines

5

Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us